Torsten Osthus

Empowering people to expand their limits and make innovations a reality inspires and drives me. Empowering People. Innovation with value. Leadership to excellence.

In our portfolio companies ZONTAL, ACCURIDS, ShardOne and Chemantics, we are working on turning innovation barriers into digital innovations for the life sciences R&D, which create benefits for everyone involved. At those companies I am not just an investor, but also an sparring partner for the management. I also support OSTHUS GmbH in strategic topics…

OSTHUS GmbH – specializing in life sciences R&D – was a big part of my entrepreneurial life. I started it, made it successful and have since sold it. In 2023, Bruker AG acquired the majority of ZONTAL with its FAIR Data Platform, that enables a digital lab landscape. I am now helping to build a manufacturer-independent software portfolio for the digitization of laboratories and manufacturing under the SciY brand, which enables the automation of processes and provides new insights and enhanced patient safety.